Stocks expected to have increasing option volume: ORCL NVDA AMD ARM SMCI
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Oracle (ORCL) PT Raised to $142 at CFRA
March 12, 2024 9:30 AM EDTCFRA analyst Angelo Zino raised the price target on Oracle (NYSE: ORCL) to $142.00 (from $130.00) while maintaining a Hold rating.
The analyst comments "We increase our 12-month target to $142 from $130, on a higher revised P/E of 21x our CY 25 EPS estimate of... More
Oracle (ORCL) PT Raised to $145 at TD Cowen
March 12, 2024 6:39 AM EDTTD Cowen analyst Derrick Wood raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "ORCL reported a solid 3Q w/ total rev growth of 7% cc in line w/ guide of 6-8%, incl.... More
Oracle (ORCL) PT Raised to $145 at Evercore ISI, 'Outlook Less Cloudy'
March 12, 2024 5:02 AM EDTEvercore ISI analyst Kirk Materne raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "Bottom line: Oracle shares are up nicely in the after-market as OCI revenue growth of 52% in c/c was in line with our expectations and importantly, F4Q guidance infers OCI growth of ~40% against a very difficult compare. The other highlight was the strength in RPO, which grew 41% in c/c excl. Cerner to $80bn and cRPO growth of ~15%. Notably, OCI revenue grew $175mn sequentially vs. $100mn last quarter.... More
Oracle (ORCL) PT Raised to $150 at Jefferies, 'F3Q: Base Hit, One Runner On'
March 12, 2024 5:01 AM EDTJefferies analyst Brent Thill raised the price target on Oracle (NYSE: ORCL) to $150.00 (from $145.00) while maintaining a Buy rating.
The analyst comments "ORCL made contact in F3Q after a disappointing F1H led by better-than-expected OCI results and 29% backlog growth. While... More
Guggenheim Reviews 'Best Idea' Oracle (ORCL) Earnings
March 12, 2024 4:59 AM EDTGuggenheim analyst John DiFucci reiterated a Buy rating and $150.00 price target on Oracle (NYSE: ORCL)
The analyst comments "ORCL surprised to the upside in OCI, and although Cloud ex. Cerner was at the low end of guidance, it was probably at least what the buy side was looking for. ORCLs results were a stark contrast to the recent decelerating business momentum of most Software names (as measured by a 2-year stack of New ARR growth see Exhibit 1). New ARR for organic Cloud accelerated to about 28% growth, and New ARR for IaaS... More
